Hiv Seroconversion Prevention
HIV Seroconversion Prevention is a biomedical intervention strategy aimed at halting the transition from HIV exposure to established infection, distinguished by its reliance on timely administration of antiretroviral agents following potential viral exposure.
284
Publications
18.4K
Citations
1.9K
Authors
643
Institutions
Publications per year
2017–2026
61
Parents
284
1–5 of 284
1.9K
8
h-index
7
h-index
San Francisco Department of Public Health, United States
7 publications · 868 citations
7
h-index
6
h-index
6
h-index
1–5 of 1.9K
643
University of California, San Francisco
San Francisco, United States
22 h-index
86 publications
9.2K citations

Johns Hopkins University
Baltimore, United States
19 h-index
94 publications
10.7K citations
University of Washington
Seattle, United States
17 h-index
64 publications
2.7K citations
Fred Hutch Cancer Center
Seattle, United States
15 h-index
49 publications
2.6K citations
London School of Hygiene & Tropical Medicine
London, United Kingdom
14 h-index
35 publications
2.1K citations
University of California, Los Angeles
Los Angeles, United States
14 h-index
25 publications
1.9K citations
Inserm
Paris, France
14 h-index
89 publications
2.8K citations
Columbia University
New York, United States
13 h-index
30 publications
1.9K citations
1–8 of 643
29 publications · 1.6K citations
22
h-index
Repository · 20 publications · 820 citations
15
h-index
18 publications · 2K citations
15
h-index
12 publications · 388 citations
12
h-index
JID · 12 publications · 1.7K citations
12
h-index
1–5